Metraipolis › archive › dc_90cb3430ddec

Comparative Outcomes of Brachyury Vaccine vs. Imatinib in Advanced Chordoma: A Mayo Clinic Experience — Europe PMC PMID:41228286

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228286
DOI
10.3390/cancers17213493
License (as archived)
solo-consultazione
Archived
2026-11-08T22:46:30.065Z
SHA-256 of the archived text
0b71abc49ac3b6d6d89e461aa6c4796d0f703dd2160cb973a876f07046cf5657
Stable URL of this page
https://metraipolis.com/documento/dc_90cb3430ddec

How to cite

Comparative Outcomes of Brachyury Vaccine vs. Imatinib in Advanced Chordoma: A Mayo Clinic Experience — Europe PMC PMID:41228286 — Europe PMC (en), https://europepmc.org/article/MED/41228286 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_90cb3430ddec (Metraipolis archive dc_90cb3430ddec, sha256 0b71abc49ac3b6d6d89e461aa6c4796d0f703dd2160cb973a876f07046cf5657)
BibTeX
@misc{dc90cb3430ddec,
  title = {Comparative Outcomes of Brachyury Vaccine vs. Imatinib in Advanced Chordoma: A Mayo Clinic Experience — Europe PMC PMID:41228286},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228286},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_90cb3430ddec; sha256 0b71abc49ac3b6d6d89e461aa6c4796d0f703dd2160cb973a876f07046cf5657},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228286. Agents can read the archived copy with the MCP tool read_document.